Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Dermatology and Therapy|August 23, 2024
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation AnalysisApril W Armstrong, Peter Foley, Yan Liu, et al.
Rheumatology and Therapy|September 11, 2024
Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 TrialsJeffrey R Curtis, Atul Deodhar, Enrique R Soriano, et al.
Arthritis Care & Research|January 28, 2015
Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week-112 Efficacy and Safety Results of the Open-Label Long-Term Extension of a Phase III, Double-Blind, Randomized, Placebo-Controlled TrialClifton O Bingham, Alan M Mendelsohn, Lilianne Kim, et al.
Free Radical Biology & Medicine|August 7, 2025
Silymarin ameliorates diet-induced gallstone formation by regulating gut microbiota-derived GCDCA to suppress ferroptosis-ROS-NFκB signaling pathwayQiang Wang, Chenglong Han, Yi Zheng, et al.
Cellular & Molecular Biology Letters|May 7, 2025
Immunodynamic axis of fibroblast-driven neutrophil infiltration in acute pancreatitis: NF-κB-HIF-1α-CXCL1Qiang Wang, Xiao Zhang, Chenglong Han, et al.
Journal of Crohn'S & Colitis|May 5, 2018
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's DiseaseBruce E Sands, Chenglong Han, Christopher Gasink, et al.
Journal of the American Academy of Dermatology|June 11, 2026
Effectiveness and safety of hematoporphyrin monomethyl ether-mediated photodynamic therapy versus pulsed dye laser for port-wine stain: a retrospective studyXiaoxue Li, Lian Liu, Ping Diao, et al.
Arthritis Care & Research|August 3, 2016
Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic ArthritisProton Rahman, Lluis Puig, Alice B Gottlieb, et al.
Journal of the American Academy of Dermatology|May 14, 2010
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trialRichard G Langley, Steven R Feldman, Chenglong Han, et al.
Arthritis Research & Therapy|October 10, 2007
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseasesChenglong Han, Josef S Smolen, Arthur Kavanaugh, et al.
Pageof 9